Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Novartis
Pharmaceuticals
GSK
AstraZeneca
Pfizer
Novo Nordisk
Johnson and Johnson
Roche
Eli Lilly
Zoetis
Topics

Advertisement

Novartis

Share

Top Latest Popular

Yesterday

Novartis to highlight Rhapsido® data across multiple immune-mediated diseases at EAACI Congress 2026 Novartis (Press Release) 08:53 Mon, 08 Jun

Friday

Novartis reports positive results from Phase III ALIGN trial for IgAN Clinical Trials Arena 10:44 Fri, 05 Jun

EULAR: Novartis Closes In On Final Approval For Cosentyx Scrip Pharma Intelligence 08:23 Fri, 05 Jun

Advertisement

Advertisement

Thursday

Novartis Vanrafia Data Show Clinically Meaningful Kidney Protection In IgA Nephropathy RTT News 12:51 Thu, 04 Jun

Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years Novartis (Press Release) 11:29 Thu, 04 Jun

Novartis Cosentyx Shows Sustained Remission In Polymyalgia Rheumatica RTT News 10:49 Thu, 04 Jun

Wednesday

Novartis Cosentyx® PMR data in New England Journal of Medicine showed sustained remission vs placebo in twice as many patients Novartis (Press Release) 16:38 Wed, 03 Jun

In the last month

Accelerating Structure Verification Across Novartis Drugs Discovery Online 19:37 Tue, 02 Jun

ASCO 2026: Mixed SCLC result for Legend’s LB2102, Novartis expedites manufacture Pharmaceutical Technology 17:13 Tue, 02 Jun

Novartis Pluvicto And Actinium Program Advance Radioligand Therapy In Prostate Cancer RTT News 09:46 Mon, 01 Jun

Novartis data at EULAR 2026 demonstrates momentum for broad immunology portfolio for complex, high unmet need diseases Novartis (Press Release) 06:30 Mon, 01 Jun

Experimental Novartis radiopharma drug shows promise in early study The Tribune, California 12:48 Sun, 31 May

Novartis experimental actinium-based drug shows promise in prostate cancer treatment: Study The Times of India 12:40 Sun, 31 May

Pluvicto™ demonstrated consistent efficacy across key patient subgroups in metastatic hormone-sensitive prostate cancer Novartis (Press Release) 07:05 Sun, 31 May

Immune Thrombocytopenia Market Forecast Signals Steady Growth During the Forecast Period (2026-2036) Backed by Pipeline Advancements | DelveInsight PR Newswire (Press Release) 15:05 Thu, 28 May

Pushing the prostate cancer treatment frontier: Radioligand therapy and beyond Novartis (Press Release) 10:27 Thu, 28 May

Novartis Points To Inflections In Neuroscience Scrip Pharma Intelligence 17:34 Wed, 27 May

Advertisement

New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength Novartis (Press Release) 06:35 Tue, 26 May

Novartis, AbbVie plan summer layoffs on opposite coasts FiercePharma 16:31 Fri, 22 May

Charcot-Marie-Tooth Disease Market Growth to Accelerate Significantly During the Forecast Period (2026-2036) Driven by the Launch of Emerging Disease-Modifying Therapies | DelveInsight PR Newswire (Press Release) 10:32 Thu, 21 May

Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA Novartis (Press Release) 06:46 Thu, 21 May

Relay drug shows early promise against rare blood vessel diseases BioPharma Dive 15:57 Tue, 19 May

Novartis terminates plant contract with Chinese CDMO Porton, threatens $64M in legal claims FiercePharma 21:28 Mon, 18 May

Novartis reveals more data behind Pluvicto expansion bid pharmaphorum 13:43 Mon, 18 May

Implied Volatility Surging for Novartis Stock Options Zacks 15:12 Wed, 13 May

Medical Services Administration, Novartis Vietnam strengthen collaboration to improve health Viet Nam News 12:29 Wed, 13 May

DeepMind spinout Isomorphic Labs raises $2.1 Billion to design drugs with AI The Hindu Business Line 12:00 Wed, 13 May

Novartis breaks ground on US radioligand therapy site PMLiVE 13:35 Tue, 12 May

Novartis India standalone net profit declines 13.82% in the March 2026 quarter The Business Standard 12:12 Tue, 12 May

Wash. Says Novartis Isn't Harmed By 340B Drug Pricing Law Law360 03:57 Tue, 12 May

A Reminder from the Fifteenth Court: Mandamus Requires More Than a Big Issue JD Supra 20:48 Mon, 11 May

What Do Patients Want Doctors to Know About Breast Cancer Recurrence? Medpage Today 16:07 Mon, 11 May

Novartis expands India role in global drug development The Times of India 10:29 Mon, 11 May

Novartis seeks to deepen India innovation play The Times of India 21:08 Sun, 10 May

How Investors May Respond To Olema Pharmaceuticals (OLMA) Adding Biopharma Deal-Maker Prakash Raman To Board Simply Wall St 18:59 Sat, 09 May

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis